THURSDAY, March 7, 2024 (HealthDay News) — Food allergies are difficult to manage at any age, but college students face complex challenges when it comes to navigating the dangers posed by the possibility of life-threatening anaphylaxis. A recent review published in the Annals of Allergy, Asthma and Immunology, the journalContinue Reading
WEDNESDAY, Feb. 28, 2024 (HealthDay News) — What if you’d been treated for years for a condition, only to find out that you’d long ago been misdiagnosed? That’s what’s happening to a sizable number of Americans who are taking allergy meds (to little effect) when in fact they have chronicContinue Reading
TUESDAY, Feb. 27, 2024 (HealthDay News) — Stuffy, sneezing, miserable: folks plagued by chronic sinusitis know the feeling all too well. Experts at University of Cincinnati Health say it’s also an all-too-common affliction, affecting an estimated 14.6% of Americans. What is chronic sinusitis? The sinuses are air-filled spaces in theContinue Reading
MONDAY, Feb. 26, 2024 (HealthDay News) — The asthma medication Xolair has proved its prowess against food allergies, with new research showing the medication substantially lowers the chances of severe reactions in patients. Data published Sunday in the New England Journal of Medicine and presented simultaneously at the American Academy of Allergy,Continue Reading
SATURDAY, Feb. 17, 2024 (HealthDay News) — Spring allergies bring to mind thoughts of stuffy noses and watery eyes. But allergies actually affect many different and interconnected systems within a person’s body, according to the American College of Allergy, Asthma and Immunology (ACAAI). “Spring allergens such as pollen, mold sporesContinue Reading
FRIDAY, Feb. 16, 2024 (HealthDay News) — People threatened by accidental exposure to foods they’re allergic to may have a new weapon of defense: On Friday, the U.S. Food and Drug Administration expanded the use of the asthma drug Xolair to help prevent anaphylactic reactions. Xolair (omalizumab) is an injectedContinue Reading
TUESDAY, Jan. 23, 2024 (HealthDay News) — If you or someone close to you suffers from severe allergic reactions, you have probably heard there are new recommendations out that offer guidance on the diagnosis, management and treatment of anaphylaxis. The latest guidelines come from Joint Task Force on Practice Parameters,Continue Reading
THURSDAY, Jan. 18, 2024 (HealthDay News) — Fetal exposure to opioids may change a baby’s immune system, triggering a rise in risks for eczema and asthma through early childhood, new research shows. Children born to women who used opioids during pregnancy had much higher rates of eczema, as well asContinue Reading
THURSDAY, Jan. 18, 2023 (HealthDay News) — Allergic to peanuts? To cats? To pollen? A new targeted therapy may have the potential to help a person ward off an allergic reaction prompted by the specific source of their allergy, Northwestern University researchers report. The therapy uses nanoparticles to deactivate mastContinue Reading
FRIDAY, Jan. 5, 2024 (HealthDay News) — Drugs already used by millions to lower cholesterol might someday have a new role: Relieving asthma and COPD. That’s the hope of a new line of research underway at the University of California, Davis. A study funded by the U.S. National Institutes ofContinue Reading
TUESDAY, Dec. 26, 2023 (HealthDay News) — Folks with allergies might want to breathe a deep, sneeze-free sigh of relief when winter rolls around. Unfortunately, the cold weather that puts pollen-producing trees and grass to sleep can also keep a person cooped up inside – increasing their risk of indoorContinue Reading
THURSDAY, Dec. 21, 2023 (HealthDay News) — Chances are you know at least one person who’s given up eating gluten. Maybe you’ve even given it up yourself. But who can really benefit from a gluten-free diet? “Gluten is one of the main proteins found in wheat, barley and rye,” saidContinue Reading
THURSDAY, Dec. 21, 2023 (HealthDay News) — A new treatment appears to reduce food allergies in children and teens, according to interim clinical trial results. A lab-made monoclonal antibody called omalizumab (Xolair) significantly increased the amounts of common foods that children could eat without sparking an allergic reaction, the U.S.Continue Reading
MONDAY, Dec. 18, 2023 (HealthDay News) — If you’re one of the 50 million Americans with asthma or allergies, 2024 is another year to redouble efforts to manage them. But how? “It’s not always easy to get allergies and asthma under control,” allergist Dr. Gailen Marshall, president of the AmericanContinue Reading